399 related articles for article (PubMed ID: 19485794)
1. Serine protease inhibitors as anti-hepatitis C virus agents.
Reiser M; Timm J
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
[TBL] [Abstract][Full Text] [Related]
2. Telaprevir: a new hope in the treatment of chronic hepatitis C?
Fowell AJ; Nash KL
Adv Ther; 2010 Aug; 27(8):512-22. PubMed ID: 20652658
[TBL] [Abstract][Full Text] [Related]
3. Emerging therapies for hepatitis C virus.
Birerdinc A; Younossi ZM
Expert Opin Emerg Drugs; 2010 Dec; 15(4):535-44. PubMed ID: 20629602
[TBL] [Abstract][Full Text] [Related]
4. New therapies for hepatitis C virus infection.
Soriano V; Peters MG; Zeuzem S
Clin Infect Dis; 2009 Feb; 48(3):313-20. PubMed ID: 19123867
[TBL] [Abstract][Full Text] [Related]
5. How to use virological tools for the optimal management of chronic hepatitis C.
de Leuw P; Sarrazin C; Zeuzem S
Liver Int; 2011 Jan; 31 Suppl 1():3-12. PubMed ID: 21205131
[TBL] [Abstract][Full Text] [Related]
6. Natural history of hepatitis C and the impact of anti-viral therapy.
Boyer N; Marcellin P
Forum (Genova); 2000; 10(1):4-18. PubMed ID: 10717254
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibitors of hepatitis C virus replication.
Neyts J
Antiviral Res; 2006 Sep; 71(2-3):363-71. PubMed ID: 16843538
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus virology and new treatment targets.
Meier V; Ramadori G
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
[TBL] [Abstract][Full Text] [Related]
9. Future directions in therapy for chronic hepatitis C.
Jensen DM; Ascione A
Antivir Ther; 2008; 13 Suppl 1():31-6. PubMed ID: 18432161
[TBL] [Abstract][Full Text] [Related]
10. Boceprevir, an NS3 protease inhibitor of HCV.
Berman K; Kwo PY
Clin Liver Dis; 2009 Aug; 13(3):429-39. PubMed ID: 19628159
[TBL] [Abstract][Full Text] [Related]
11. Telaprevir: hope on the horizon, getting closer.
Weisberg IS; Jacobson IM
Clin Liver Dis; 2009 Aug; 13(3):441-52. PubMed ID: 19628160
[TBL] [Abstract][Full Text] [Related]
12. Treating HCV with ribavirin analogues and ribavirin-like molecules.
Gish RG
J Antimicrob Chemother; 2006 Jan; 57(1):8-13. PubMed ID: 16293677
[TBL] [Abstract][Full Text] [Related]
13. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.
Welsch C; Jesudian A; Zeuzem S; Jacobson I
Gut; 2012 May; 61 Suppl 1():i36-46. PubMed ID: 22504918
[TBL] [Abstract][Full Text] [Related]
14. Future treatment of chronic hepatitis C.
Keeffe EB
Antivir Ther; 2007; 12(7):1015-25. PubMed ID: 18018759
[TBL] [Abstract][Full Text] [Related]
15. [Direct antiviral treatment strategies in chronic hepatitis C].
Neumann-Haefelin C; Blum HE; Thimme R
Dtsch Med Wochenschr; 2012 Jun; 137(25-26):1360-5. PubMed ID: 22653493
[TBL] [Abstract][Full Text] [Related]
16. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.
Lamarre D; Anderson PC; Bailey M; Beaulieu P; Bolger G; Bonneau P; Bös M; Cameron DR; Cartier M; Cordingley MG; Faucher AM; Goudreau N; Kawai SH; Kukolj G; Lagacé L; LaPlante SR; Narjes H; Poupart MA; Rancourt J; Sentjens RE; St George R; Simoneau B; Steinmann G; Thibeault D; Tsantrizos YS; Weldon SM; Yong CL; Llinàs-Brunet M
Nature; 2003 Nov; 426(6963):186-9. PubMed ID: 14578911
[TBL] [Abstract][Full Text] [Related]
17. Improving anti-HCV therapy.
Pol S; Mallet VO
Discov Med; 2006 Oct; 6(35):187-90. PubMed ID: 17234140
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of the new DAAs for the treatment of hepatitis C virus infection: virology and resistance.
Chevaliez S
Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S46-51. PubMed ID: 22248694
[TBL] [Abstract][Full Text] [Related]
19. [Boceprevir: new possibilities for antiviral treatment of chronic hepatitis C].
Nikitin IG; Baĭkova IE; Gogova LM; Volynkina VM; Kisliakov VA
Ter Arkh; 2013; 85(2):76-84. PubMed ID: 23653945
[TBL] [Abstract][Full Text] [Related]
20. Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061.
Herrmann E; Zeuzem S; Sarrazin C; Hinrichsen H; Benhamou Y; Manns MP; Reiser M; Reesink H; Calleja JL; Forns X; Steinmann GG; Nehmiz G
Antivir Ther; 2006; 11(3):371-6. PubMed ID: 16759054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
